Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: Role in irritable bowel syndrome

Expert Review of Gastroenterology and Hepatology

Volumn 8, Issue 7, 2014, Pages 819-834

  Tuck, Caroline J ^a   Muir, Jane G ^a   Barrett, Jacqueline S ^a   Gibson, Peter R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

abdominal pain; carbohydrates; diet therapy; FODMAP; gastrointestinal diseases; irritable bowel syndrome

Indexed keywords

CARBOHYDRATE DERIVATIVE; DISACCHARIDE; ERYTHRITOL; FERMENTABLE OLIGOSACCHARIDE DISACCHARIDE MONOSACCHARIDE AND POLYOL; FRUCTAN; FRUCTOSE; GALACTOSE OLIGOSACCHARIDE; ISOMALT; LACTITOL; LACTOSE; MALTITOL; MANNITOL; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL; SORBITOL; UNCLASSIFIED DRUG; XYLITOL; POLYMER;

CARBOHYDRATE ABSORPTION; CLINICAL EFFECTIVENESS; DIET RESTRICTION; DIETARY FIBER; DISEASE ASSOCIATION; FERMENTATION; FOOD COMPOSITION; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; INTESTINE TRANSIT TIME; IRRITABLE COLON; LACTOSE INTOLERANCE; LONG TERM CARE; LOW CARBOHYDRATE DIET; NONHUMAN; NUTRITIONAL REQUIREMENT; REVIEW; RISK BENEFIT ANALYSIS; SMALL INTESTINE ABSORPTION; TREATMENT RESPONSE; DIET THERAPY; DISEASE MANAGEMENT; GASTROINTESTINAL TRACT; IRRITABLE BOWEL SYNDROME; METABOLISM; MICROBIOLOGY; MICROFLORA; PATIENT EDUCATION; TREATMENT OUTCOME;

DIET, CARBOHYDRATE-RESTRICTED; DISACCHARIDES; DISEASE MANAGEMENT; FERMENTATION; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; MICROBIOTA; MONOSACCHARIDES; OLIGOSACCHARIDES; PATIENT EDUCATION AS TOPIC; POLYMERS; TREATMENT OUTCOME;

EID: 84906347797     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2014.917956     Document Type: Review

References (101)

1. Silk DB. Impact of irritable bowel syndrome on personal relationships and working practices. Eur J Gastroenterol Hepatol 2001;13(11):1327-32
2. Heading R, Bardhan K, Hollerbach S, et al. Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome-a European perspective. Aliment Pharmacol Ther 2006;24(2):207-36
3. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. American college of gastroenterology task force on irritable bowel syndrome. Am J Gastroenterol 2009;104:S1-35
4. Bohn L, Storsrud S, Simren M. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol Motil 2013; 25(1):23-30.e21
5. Andrews E, Eaton S, Hollis K, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005;22(10):935-42
6. Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am 2011;40(1): 11-19
7. Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009;43(6):541
8. Anastasi JK, Capili B, Chang M. Managing irritable bowel syndrome. Am J Nurs 2013; 113(7):42-52
9. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol 2012;107(5):657-66
10. Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology 2006;130(5): 1377-90
11. Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 2011;107(2):276-85
12. Eswaran S, Tack J, Chey WD. Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am 2011;40(1):141-62
13. Yao CK, Gibson PR, Shepherd SJ. Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders. Am J Gastroenterol 2013;108(5):748-58
14. Floch MH, Narayan R. Diet in the irritable bowel syndrome. J Clin Gastroenterol 2002; 35(1):S45-52
15. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106(3):508-14
16. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported Non-Celiac Gluten Sensitivity following dietary reduction of low-fermentable, poorly-absorbed, short-chain carbohydrates. Gastroenterology 2013; 145(2):320-8
17. Reding KW, Cain KC, Jarrett ME, et al. Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome. Am J Gastroenterol 2013;108:270-6
18. Lomer M, Parkes G, Sanderson J. Review article: lactose intolerance in clinical practice-myths and realities. Aliment Pharmacol Ther 2008;27(2):93-103
19. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000; 2(8):583-7
20. Shepherd SJ, Gibson PR, Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106(10):1631-9
21. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6(7):765-71
22. Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005;21(12):1399-409
23. Muir JG, Shepherd SJ, Rosella O, et al. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007;55(16):6619
24. Muir JG, Rose R, Rosella O, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 2009;57(2):554
25. Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24(2): 154-76
26. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24(5):487-95
27. Staudacher HM, Lomer MCE, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142(8):1510-18
28. De Roest RH, Dobbs BR, Chapman BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013;67(9):895-903
29. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146(1):67-75.e65
30. Ludidi S, Conchillo J, Keszthelyi D, et al. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff. Neurogastroenterol Motil 2012;24(8):729-e346
31. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25(8):1366-73
32. Blakemore SJ, Aledo JC, James J, et al. The Glut5 hexose transporter is also localized to the basolateral membrane of the human jejunum. Biochem J 1995;309:7-12
33. Jones HF, Butler RN, Brooks DA Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2011;300:G202-6
34. DeBosch BJ, Chi M, Moley KH. Glucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization. Endocrinology 2012; 153(9):4181-91
35. Cheeseman C. GLUT7: a new intestinal facilitated hexose transporter. Am J Physiol-Endocrinol Metab 2008;295:E238-41
36. Thorens B, Mueckler M, Thorens B, Mueckler M. Glucose transporters in the 21st century. Am J Physiol 2010;298(2): E141
37. Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (Fermentable Oligo-, Di-, MonoSaccharides and Polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2013;109: 110-19
38. Frieling T, Kuhlbusch-Zicklam R, Kalde S, et al. Fructose Malabsorption: how much fructose can a healthy subject tolerate? Digestion 2011;84(4):269-72
39. Barrett JS, Irving PM, Shepherd SJ, et al. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009;30(2):165-74
40. Wilder-Smith CH, Li X, Ho SS, et al. Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance. United Eur Gastroenterol J 2014;2(1):14-21
41. Biesiekierski JR. Fructose-induced symptoms beyond malabsorption in FGID. United Eur Gastroenterol J 2014;2(1):10-13
42. Bate JP, Irving PM, Barrett JS, Gibson PR. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol 2010;22(3):318-26
43. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21(11):1391-5
44. Shaukat A, Levitt MD, Taylor BC, et al. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med 2010;152(12):797-803
45. Itan Y, Jones BL, Ingram CJ, et al. A worldwide correlation of lactase persistence phenotype and genotypes. BMC Evol Biol 2010;10:36
46. O'Connell S, Walsh G. Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance. Appl Biochem Biotechnol 2006;134(2):179-91
47. O'Connell S, Walsh G. A novel acid-stable, acid-active beta-galactosidase potentially suited to the alleviation of lactose intolerance. Appl Microbiol Biotechnol 2010;86(2):517-24
48. Lin MY, Dipalma JA, Martini MC, et al. Comparative effects of exogenous lactase (beta-galactosidase) preparations on in vivo lactose digestion. Dig Dis Sci 1993;38(11): 2022-7
49. Portincasa P, Di Ciaula A, Vacca M, et al. Beneficial effects of oral tilactase on patients with hypolactasia. Eur J Clin Invest 2008; 38(11):835-44
50. Gibson GR, Probert HM, Van Loo J, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17(2):259-75
51. Tosh SM, Yada S. Dietary fibres in pulse seeds and fractions: characterization, functional attributes, and applications. Food Res Int 2010;43(2):450-60
52. Reddy BS. Possible mechanisms by which pro-and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 1999;129(7):1478S-82s
53. Guillon F, Champ MM. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr 2002;88(Suppl 3):S293-306
54. Taylor G, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr 1998;80(4):S225-30
55. Fukumoto S, Tatewaki M, Yamada T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol 2003;284(5):R1269-76
56. Roberfroid MB. Inulin-type fructans: functional food ingredients. J Nutr 2007; 137(11):2493S-502S
57. Winham DM, Hutchins AM. Perceptions of flatulence from bean consumption among adults in 3 feeding studies. Nutr J 2011;10:128
58. Frias J, Doblado R, Vidal-Valverde C, et al. Kinetics of soluble carbohydrates by action of endo/exo a-galactosidase enzyme in lentils and peas. Eur Food Res Technol 2003;216(3):199-203
59. Roberfroid M. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 1993;33(2):103-48
60. Roberfroid M, Delzenne NM. Dietary fructans. Annu Rev Nutr 1998;18(1):117-43
61. Rumessen JJ, Gudmand-Høyer E. Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr 1998;68(2): 357-64
62. Loo JV, Clune Y, Bennett M, Collins JK. The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr 2005;93(S1): S91-8
63. Kleessen B, Hartmann L, Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr 2003;89(05): 597-606
64. Nyman M. Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 2002;87(S2):S163-8
65. Yao C, Tan HL, Langenberg D, et al. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 2013;27:264
66. Beaugerie L, Flourie B, Marteau P, et al. Digestion and absorption in the human intestine of three sugar alcohols. Gastroenterology 1990;99(3):717-23
67. Barrett JS. Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutr Clin Pract 2013;28(3):300-6
68. Ostgaard H, Hausken T, Gundersen D, El-Salhy M. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012;5(6): 1382-90
69. Shepherd SJ, Lomer MC, Gibson PR Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013;108(5):707-17
70. Gearry RB, Irving PM, Barrett JS, et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009;3(1):8-14
71. Komericki P, Akkilic-Materna M, Strimitzer T, et al. Oral xylose isomerase decreases breath hydrogen excretion and improves gastrointestinal symptoms in fructose malabsorption-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2012;36(10):980-7
72. Barrett JS, Kalubovila U, Irving PM, Gibson PR. Semiquantitative assessment of breath hydrogen testing. J Gastroenterol Hepatol 2013;28(9):1450-6
73. Wilder-smith CH, Materna A, Wermelinger C, Schuler J. Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther 2013;37(11):1074-83
74. Barrett J, Ng PS, Muir J, Gibson P. Letter: oral fructose-breath hydrogen response, symptoms, both or neither? Aliment Pharmacol Ther 2013;38(4):442-3
75. Eadala P, Matthews S, Waud J, et al. Association of lactose sensitivity with inflammatory bowel disease-demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther 2011;34(7):735-46
76. Lauritano EC, Gabrielli M, Lupascu A, et al. Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 22(1):31-5
77. Gibson PR, Barrett JS. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition 2010;26(11-12): 1038-43
78. Lindberg DA Hydrogen breath testing in adults: what is it and why is it performed? Gastroenterol Nurs 2009;32(1):19-24
79. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011;60(3):334-40
80. Payne AN, Chassard C, Lacroix C, et al. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 2012;13(9):799-809
81. Halmos EP, Christophersen CT, Bird AR, et al. The low FODMAP diet alters the composition of the colonic microbiota compared to a typical Australian intake in patients with irritable bowel syndrome: a randomised controlled cross-over trial. J Gastroenterol Hepatol 2013;28(Suppl 2):122
82. Park Y, Hunter DJ, Spiegelman D, et al. Dietary fiber intake and risk of colorectal cancer. JAMA 2005;294(22):2849-57
83. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011;106(4): 563-73
84. Croagh C, Shepherd SJ, Berryman M, et al. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007;13(12):1522-8
85. Barrett JS, Gibson PR Development and validation of a comprehensive semi quantitative food frequency questionnaire that includes FODMAP intake and glycemic Index. J Am Diet Assoc 2010; 110 (10):1469-76
86. Le Neve B, Posserud I, Bohn L, et al. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome. Am J Gastroenterol 2013;108(5):786-95
87. Ledochowski M, Widner B, Bair H, et al. Fructose-and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000;35(10): 1048-52
88. Ledochowski M, Widner B, Murr C, et al. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 2001;36(4):367-71
89. Rodrigo L, Blanco I, Bobes J, de Serres FJ. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther 2013; 15(6):R201
90. Gibson PR, Muir JG. Not all effects of a gluten-free diet are due to removal of gluten. Gastroenterology 2013;145(3):693
91. Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013; 144(5):903-11
92. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010;31(8): 874-82
93. Jones HF, Butler RN, Moore DJ, Brooks DA. Developmental changes and fructose absorption in children: effect on malabsorption testing and dietary management. Nutr Rev 2013;71(5):300-9
94. Jones HF, Burt E, Dowling K, et al. Effect of age on fructose malabsorption in children presenting with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2011;52(5): 581-4
95. Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 2008;295(2):E227-37
96. Choi YK, Kraft N, Zimmerman B, et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol 2008;42(3):233-8
97. Rumessen JJ, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. comparison with sucrose and its constituent monosaccharides. Gut 1986; 27(10):1161
98. Truswell AS, Seach JM, Thorburn A. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988;48(6): 1424-30
99. Kneepkens CM, Jakobs C, Douwes AC. Apple juice, fructose, and chronic nonspecific diarrhoea. Eur J Pediatr 1989; 148(6):571-3
100. Tuck CJ, Barrett JS, Smith S, et al. Minimising the impact of high fructose foods for patients with irritable bowel syndrome: investigating the use of added glucose to assist with fructose absorption. AMJ, Proceedings of the Nutrition Society of Australia 2013;6(11):13
101. Monash University. The Monash University Low FODMAP App. Available from: http://www.med.monash.edu/cecs/gastro/fodmap/